RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karam F. Soliman to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Karam F. Soliman has written about Tumor Necrosis Factor-alpha.
Connection Strength

3.527
  1. Mendonca P, Alghamdi S, Messeha S, Soliman KFA. Pentagalloyl glucose inhibits TNF-a-activated CXCL1/GRO-a expression and induces apoptosis-related genes in triple-negative breast cancer cells. Sci Rep. 2021 03 11; 11(1):5649.
    View in: PubMed
    Score: 0.684
  2. Bauer D, Mazzio E, Soliman KFA. Whole Transcriptomic Analysis of Apigenin on TNFa Immuno-activated MDA-MB-231 Breast Cancer Cells. Cancer Genomics Proteomics. 2019 Nov-Dec; 16(6):421-431.
    View in: PubMed
    Score: 0.623
  3. Mendonca P, Horton A, Bauer D, Messeha S, Soliman KFA. The inhibitory effects of butein on cell proliferation and TNF-a-induced CCL2 release in racially different triple negative breast cancer cells. PLoS One. 2019; 14(10):e0215269.
    View in: PubMed
    Score: 0.622
  4. Bauer D, Redmon N, Mazzio E, Soliman KF. Apigenin inhibits TNFa/IL-1a-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells. PLoS One. 2017; 12(4):e0175558.
    View in: PubMed
    Score: 0.523
  5. Ahmed SA, Mendonca P, Messeha SS, Oriaku ET, Soliman KFA. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells. Molecules. 2023 Dec 21; 29(1).
    View in: PubMed
    Score: 0.207
  6. Adinew GM, Messeha S, Taka E, Mochona B, Redda KK, Soliman KFA. Thymoquinone Inhibition of Chemokines in TNF-a-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells. Int J Mol Sci. 2023 Jun 08; 24(12).
    View in: PubMed
    Score: 0.200
  7. Messeha SS, Zarmouh NO, Antonie L, Soliman KFA. Sanguinarine Inhibition of TNF-a-Induced CCL2, IKBKE/NF-?B/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells. Int J Mol Sci. 2022 Jul 28; 23(15).
    View in: PubMed
    Score: 0.188
  8. Kanga KJW, Mendonca P, Soliman KFA, Ferguson DT, Darling-Reed SF. Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. Anticancer Res. 2021 Dec; 41(12):5919-5933.
    View in: PubMed
    Score: 0.180
  9. Messeha SS, Zarmouh NO, Mendonca P, Alwagdani H, Kolta MG, Soliman KFA. The inhibitory effects of plumbagin on the NF-?B pathway and CCL2 release in racially different triple-negative breast cancer cells. PLoS One. 2018; 13(7):e0201116.
    View in: PubMed
    Score: 0.143
  10. Bauer D, Mazzio E, Soliman KF, Taka E, Oriaku E, Womble T, Darling-Reed S. Diallyl disulfide inhibits TNFa-induced CCL2 release by MDA-MB-231 cells. Anticancer Res. 2014 Jun; 34(6):2763-70.
    View in: PubMed
    Score: 0.107
  11. Kanga KJW, Kanga LHB, Mendonca P, Soliman KFA, Ferguson DT, Reed SL, Darling-Reed S. Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-a-induced Triple Negative Breast Cancer Cells. Anticancer Res. 2023 Jun; 43(6):2393-2405.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support